Association of Statin Use with Risk and Outcome of Acute Kidney Injury in Community-Acquired Pneumonia
Authors:
- Raghavan MuruganRMRaghavan Murugan
- Lisa WeissfeldLWLisa Weissfeld
- Sachin YendeSYSachin Yende
- Kai SingbartlKSKai Singbartl
- Derek C. AngusDADerek C. Angus
- John A. KellumJKJohn A. Kellum
- 1 June 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 7 (6) , 895-905
Abstract
Summary: Background and objectives: Sepsis is a leading cause of AKI. Animal studies suggest that the pleiotropic effect of statins attenuates the risk for AKI and decreases mortality. This study examined whether statin use was associated with a lower risk for pneumonia-induced AKI and 1-year and cause-specific mortality in patients with AKI. Design, setting, participants, & measurements: Multicenter, prospective cohort study of 1836 patients hospitalized with community-acquired pneumonia. Results: Baseline characteristics differed among statin users and nonusers. Of the 413 patients (22.5%) who received a statin before hospitalization, statin treatment, when adjusted for differences in age, severity of pneumonia, admission from nursing home, health insurance, and propensity for statin use, did not reduce the risk for AKI (odds ratio [OR], 1.32 [95% confidence interval (CI), 1.02–1.69]; P=0.05). Of patients with AKI (n=631), statin use was associated with a lower risk for death at 1 year (27.8% versus 38.8%; P=0.01), which was not significant when adjusted for differences in age, severity of pneumonia and AKI, use of mechanical ventilation, and propensity score (OR, 0.72 [95% CI, 0.50–1.06]; P=0.09). Among patients with AKI, cardiovascular disease accounted for one third of all deaths. Conclusions: In a large cohort of patients hospitalized with pneumonia, statins did not reduce the risk for AKI. Among patients with AKI, statin use was not associated with lower risk for death at 1 year. The higher risk for AKI observed among statin users may be due to indication bias.Keywords
This publication has 36 references indexed in Scilit:
- Understanding the potential role of statins in pneumonia and sepsis*Critical Care Medicine, 2011
- Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome*Critical Care Medicine, 2011
- Acute kidney injury: what's the prognosis?Nature Reviews Nephrology, 2011
- Long-term risk of mortality after acute kidney injury in patients with sepsis: a contemporary analysisBMC Nephrology, 2010
- Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survivalKidney International, 2010
- Understanding the Inflammatory Cytokine Response in Pneumonia and SepsisArchives of internal medicine (1960), 2007
- Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort studyBMJ, 2006
- Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effectsKidney International, 2006
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986